What You Need to Know About Immune-Onc Therapeutics Post author:Sam Post published:January 24, 2018 Post category:BioPharma Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace You Might Also Like Daiichi Sankyo's Tumor Drug Meets Primary Endpoint in Late-Stage Study October 30, 2017 <b>BeneVir</b> Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets April 24, 2017 INC Research Schedules Fourth Quarter And Year End 2016 Earnings Call For Tuesday, February 28, 2017 February 6, 2017
<b>BeneVir</b> Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H And Other Platform Assets April 24, 2017
INC Research Schedules Fourth Quarter And Year End 2016 Earnings Call For Tuesday, February 28, 2017 February 6, 2017